Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Changchun BCHT Biotechnology Co's EV-to-FCF or its related term are showing as below:
SHSE:688276'
s EV-to-FCF Range Over the Past 10 Years
Min: -241.26 Med: -66.27 Max: -37.6
Current: -69
During the past 9 years, the highest EV-to-FCF of Changchun BCHT Biotechnology Co was -37.60. The lowest was -241.26. And the median was -66.27.
SHSE:688276's EV-to-FCF is ranked worse than 100% of 565
companies
in the Drug Manufacturers industry
Industry Median: 20.96
vs SHSE:688276: -69.00
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Changchun BCHT Biotechnology Co (SHSE:688276) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Changchun BCHT Biotechnology Co's PE Ratio (TTM) for today is calculated as:
Changchun BCHT Biotechnology Co's share price for today is ¥14.73.
Changchun BCHT Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.650.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Changchun BCHT Biotechnology Co EV-to-FCF Related Terms
Changchun BCHT Biotechnology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Changchun BCHT Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Changchun BCHT Biotechnology Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Changchun BCHT Biotechnology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Changchun BCHT Biotechnology Co's EV-to-FCF falls into.
Changchun BCHT Biotechnology Co's current Enterprise Value is ¥6,216.2 Mil.
Changchun BCHT Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-90.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changchun BCHT Biotechnology Co (SHSE:688276) has a EV-to-FCF of -69.00 as of Jul. 20, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Changchun BCHT Biotechnology Co and its competitors. According to the industry distribution chart, Changchun BCHT Biotechnology Co ranks #999999 out of 565 companies in the Drug Manufacturers industry.
Is Changchun BCHT Biotechnology Co's EV-to-FCF too high?
Changchun BCHT Biotechnology Co's current EV-to-FCF is -69.00. Based on the distribution chart, Changchun BCHT Biotechnology Co ranks #999999 out of 565 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Changchun BCHT Biotechnology Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Changchun BCHT Biotechnology Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Changchun BCHT Biotechnology Co ranks #999999 out of 565 companies for EV-to-FCF. This places Changchun BCHT Biotechnology Co in the lower half of its industry. The industry median EV-to-FCF is 20.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Changchun BCHT Biotechnology Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Changchun BCHT Biotechnology Co's current EV-to-FCF is -69.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Changchun BCHT Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Changchun BCHT Biotechnology Co (SHSE:688276) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥18.57, compared to a current price of ¥14.73 — trading 20.7% below its estimated fair value. The current EV-to-FCF is -69.00. Changchun BCHT Biotechnology Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Changchun BCHT Biotechnology Co (SHSE:688276), the current EV-to-FCF is -69.00 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Changchun BCHT Biotechnology Co (SHSE:688276) Overvalued in 2026?
Based on GuruFocus' analysis, Changchun BCHT Biotechnology Co stock appears to be undervalued.
The current stock price of ¥14.73 is trading 20.7% below its estimated GF Value™ of ¥18.57.
GuruFocus considers Changchun BCHT Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688276:
EV-to-FCF: -69.00
GF Value™: ¥18.57 vs. price of ¥14.73 (20.7% below fair value)
No single metric tells the full story. See the SHSE:688276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Changchun BCHT Biotechnology Co Business Description
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
66GF Score
Get the complete analysis for SHSE:688276
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688276 has been successfully added to your 
